The study focused on observing the clinical effects of myopia control in children aged 5 to 18. The participants were non-randomly assigned to two groups based on their willingness to undergo visual therapy: Defocus Incorporated Multiple Segments lens group (DIMS group) and the combined group of DIMS lenses and visual therapy (combined group). A retrospective observational study was conducted on the data from 230 eyes of enrolled children after a 6-month follow-up, revealing that all enrolled children exhibited slow myopia progression, with an average spherical equivalent(SE) progression of (-0.07±0. 18)D/half year and an average axial elongation of (0.04±0. 15) mm/half year. There was no statistical difference in the degree of spherical equivalent progression between the two treatment groups(X2=3.200, P>0.05), but there was a statistical diference in the degree of axial elongation progression (X2=10.667, P<0.05). In conclusion, through 6-month clinical follow-up, it was found that myopic children wearing DIMS lenses can achieve effective control over myopia (SE) progression and axial elongation;furthermore,simultaneous visual therapy may provide additional benefits for controlling axial elongation.